Antibody-cytokine fusion breathes new life into glioblastoma therapy.
Juyeun LeeMichael NicosiaJustin D LathiaPublished in: Science translational medicine (2023)
An antibody-cytokine fusion molecule combined with chemotherapy induces tumor regression in mice and patients with recurrent glioblastoma by boosting antitumor immunity (Look et al. ).